Production expansion — new opportunities for patients

The launch of the company’s new production capacities is scheduled for the 2d quarter of 2026.

At present, construction of manufacturing facilities is underway, along with preparation for the delivery of process equipment. Once operation at full capacity, the facility will be able to produce up to 3 million liters of products per year (including powdered formulas in liquid equivalent) and will fully meet the demand for tube feeding nutrition market in Russia.

Today, among enteral nutrition manufactures, our specialized products are most in demand in the country’s hospital sector. In addition, based on the results of the first half of 2025, Nutrien brand holds a leading position in terms of hospital sale’s volume.

Our product portfolio includes special formulas for patients with a wide range of conditions, including gastritis, diabetes, stroke, chronic respiratory diseases, liver and kidney failure, oncology, and more. We also offer nutrition solutions for healthy individuals with increased nutrition needs.

Nutrien products are used in leading medical institutions across the country, including The National Medical Research Center of pediatric hematology, oncology and immunology named after Dmitry Rogachev, N.V.  Sklifosovsky Research Institute for Emergency Medicine, St. Petersburg I.I. Dzhanelidze Research Institute of Emergency Medicine, Morozov Children’s City Clinical Hospital and other clinics.

Our products are available through pharmacy channels across Russia and are supplied for export.